US Stock MarketDetailed Quotes

HRTX Heron Therapeutics

Watchlist
  • 1.740
  • -0.060-3.33%
Close Oct 31 16:00 ET
  • 1.780
  • +0.040+2.30%
Post 17:35 ET
263.90MMarket Cap-6960P/E (TTM)

Heron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Heron Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
36.63M
+16.51%
EPS
-0.03
+80.46%
Analyst Rating
Buy

Oct 31, 2024

Heron Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 40.200M--
Nov 12, 20242024/Q3-- / 36.625M--
Aug 6, 20242024/Q236.024M / 35.888M--
May 7, 20242024/Q134.670M / 32.975M--
Mar 12, 20242023/Q434.233M / 31.217M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 40.200M--
Nov 12, 20242024/Q3-- / 36.625M--
Aug 6, 20242024/Q236.024M / 35.888M--
May 7, 20242024/Q134.670M / 32.975M--
Mar 12, 20242023/Q434.233M / 31.217M--

Unlock Free Earnings Estimates

Heron Therapeutics Earnings Reports

  • Heron Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:09 ET

  • Heron Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 08:09 ET

  • Heron Therapeutics | 10-K: FY2023 Annual Report

    Mar 12 16:19 ET

  • Heron Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data